Bacman S, Sterin-Borda L, Lustig L, Denduchis B, Borda E
Centro de Estudios Farmacológicos y de Principios Naturales, Universidad de Buenos Aires, Argentina.
Can J Physiol Pharmacol. 1990 Apr;68(4):539-44. doi: 10.1139/y90-078.
Antilaminin IgG bound to cholinergic muscarinic receptors of normal mice heart and simulated the biological effect of a cholinergic agonist. Antilaminin IgG interfered with the binding of the radiolabelled muscarinic antagonist, (-)-[3H]quinuclidinyl benzilate, in a noncompetitive fashion. The interaction of antilaminin IgG with the muscarinic cholinergic receptor increased production of cGMP and decreased production of cAMP. Antilaminin IgG also decreased the contractile tension of mouse atria. Both the mechanical and enzymatic effect of antilaminin IgG required the activation of the muscarinic cholinergic system because they were blunted by atropine and mimicked by acetylcholine.
抗层粘连蛋白IgG与正常小鼠心脏的胆碱能毒蕈碱受体结合,并模拟胆碱能激动剂的生物学效应。抗层粘连蛋白IgG以非竞争性方式干扰放射性标记的毒蕈碱拮抗剂(-)-[3H]奎宁环基苯甲酸酯的结合。抗层粘连蛋白IgG与毒蕈碱胆碱能受体的相互作用增加了cGMP的产生并减少了cAMP的产生。抗层粘连蛋白IgG还降低了小鼠心房的收缩张力。抗层粘连蛋白IgG的机械和酶促作用都需要激活毒蕈碱胆碱能系统,因为它们被阿托品减弱并被乙酰胆碱模拟。